Introduction
Diabetes Mellitus is a very common metabolic disorder and it is an independent risk factor for stroke and is associated with 2 to 6 fold increased risk compared with non-diabetic subjects and worsens survival of patients with acute stroke. The combination stroke and Diabetes Mellitus is associated with worse stroke related outcome, high disability and stroke recurrence. Approximately 20% of patients with Diabetes die from stroke.1, 2 The incidence of stroke increases as the age progresses and the number of stroke patients is projected to increase in elderly population. Stroke is more commonly seen in Males when compared to females.3 The mechanism is believed to be accelerated atherosclerosis, which can affect vessels in many distributions, including small and large vessels.4
Glucose intolerance or even fasting hyperglycemia may follow an acute vascular event, and ensuing physical inactivity and poor food intake may lead to continued glucose intolerance. Thus, glucose intolerance in a stroke patient may or may not reflect glycemia prior to the event. Measurement of HbA1C rather than glucose as an indicator of prior glycemia offers a new perspective. The rate of non-enzymic glycosylation of hemoglobin is believed to depend largely or solely on plasma glucose concentration.5 Since the erythrocyte survives about 3 months, HbA1C measurements in patients with normal erythrocyte survival reflect plasma glucose concentrations during that period.
Table 1
Materials and Methods
Source of data
The information for the study will be collected from Patients with Acute Ischemic Stroke admitted to BLDEU’S SHRI B. M. PATIL MEDICAL COLLEGE HOSPITAL and RESEARCH CENTRE VIJAYAPUR between December 2016 to June 2018.
Method of collection of data (including sampling procedure if any)
Type of study - Cross sectional study.
With the proportion of stroke 50% at 95% confidence interval & 5% precesion calculated sample size is 64.
It is known that Ischemic stroke accounts for 80%of the Stroke.(67)
n = Z2 *p *(1-p) e2 Z - Z value at 95% Confidence interval. P - Proportion rate. E - Margin of error.
Hence 64 Ischemic stroke cases will be included in the study.
Study design
Estimation of Random blood glucose and HbA1c levels were done at the time of admission.
Patients were scored severity based on NIH stroke scale at the time of admission
Hba1c levels <6% indicates well controlled,6-9% indicates fairly controlled,>9% indicates poorly controlled
Infarct size on CT/MRI scan brain <3cm2 is small,3-5cm2 is moderate and >5cm2 is large infarct.
NIHSS score 0-4 indicates minor stroke, 5-15 indicates mild to moderate,16-20 indicates severe and 21-42 indicates very severe neurologic impairment.
Results
Table 2
Age (Years) |
No. of patients |
Percentage |
< 40 |
1 |
1.6 |
40 – 49 |
8 |
12.5 |
50 – 59 |
12 |
18.8 |
60 – 69 |
22 |
34.4 |
70 – 79 |
13 |
20.3 |
80+ |
8 |
12.5 |
Total |
64 |
100.0 |
Table 4
HbA1C |
No. of patients |
Percentage |
< 6.00 |
25 |
39.1 |
6.00 - 9.00 |
16 |
25.0 |
9.0+ |
23 |
35.9 |
Total |
64 |
100.0 |
Table 5
Infarct class |
Infarct Size |
No. of patients |
Percentage |
A |
< 3 |
25 |
39.1 |
B |
3 -5 |
13 |
20.3 |
C |
>5 |
26 |
40.6 |
|
Total |
64 |
100.0 |
Table 6
Risk Factors |
No. of patients |
Percentage |
T2DM |
13 |
20.3 |
T2DM,SM |
15 |
23.4 |
T2DM,HTN,SM |
3 |
4.7 |
T2DM,HTN,DYS |
5 |
7.9 |
T2DM,HTN |
18 |
28.2 |
T2DM,DYS |
7 |
10.8 |
T2DM,RHD |
2 |
3.1 |
T2DM,RVD |
1 |
1.6 |
Total |
64 |
100.0 |
Table 10
Cranial Nerve Involvement |
No. of patients |
Percentage |
Present |
35 |
54.7 |
Absent |
29 |
45.3 |
Total |
64 |
100.0 |
|
|
|
Table 0
10a |
|
|
Language Disturbance |
No. of patients |
Percentage |
Present |
29 |
45.3 |
Absent |
35 |
54.7 |
Total |
64 |
100.0 |
Table 11
Severity |
Score |
No. of patients |
Percentage |
Minor stroke |
0-4 |
0 |
0 |
Moderate Stroke |
5-15 |
24 |
37.5 |
Moderate to Severe |
16-20 |
14 |
21.9 |
Severe Stroke |
21-42 |
26 |
40.6 |
Total |
|
64 |
100.0 |
Table 12
Descriptive Statistics |
||||
X |
Minimum |
Maximum |
Mean |
Std. Deviation |
Age |
35 |
90 |
63.59 |
12.558 |
NIHSS score |
8 |
35 |
19.55 |
7.719 |
Blood glucose on admission |
80 |
420 |
212.23 |
88.907 |
HbA1C |
4.50 |
12.80 |
7.6766 |
2.27594 |
Table 13
In this study well controlled Diabetes has moderate stroke severity, fairly controlled Diabetes has moderate to severe stroke severity and poorly controlled Diabetes has severe stroke. It is observed that severity of the presenting complaints worsened from well controlled Diabetes to poorly controlled Diabetes. The NIHSS score correlates with the HbA1C, with increase in severity of the stroke from well controlled Diabetes to poorly controlled Diabetes.
Table 14
Most of the small sized infarcts occurred in the well controlled Diabetes group, medium sized infarcts in fairly controlled Diabetes and most of the larged sized infarcts in the diabetes group.
In the well controlled Diabetes group, 96% has small sized infarcts and 4% had medium sized infarcts. There were no larged sized infarcts.
In the fairly controlled Diabetes group, 6.2% has small sized infarcts, 75% of patients has medium sized infarcts and 18.8% of patients has larged sized infarcts in poorly controlled Diabetes group, 100% of patients has larged sized infarcts.
Table 15
In this study it is observed that, NIHSS score is lowest in the well controlled Diabetes.
Summary
In this study well controlled Diabetes has moderate stroke severity, fairly controlled Diabetes has moderate to severe stroke severity and poorly controlled Diabetes has severe stroke.
It is observed that severity of the presenting complaints worsened from well controlled Diabetes to poorly controlled Diabetes.
The NIHSS score correlates with the HbA1C, with increase in severity of the stroke from well controlled Diabetes to poorly controlled Diabetes.
Conclusion
Severity of the score increases as the infarct size increases.
Poorly controlled Diabetes has more severe stroke as per NIHSS score with large sized infarcts.
Stroke is a medical emergency and can cause permanent neurological damage, complications and death.
National Institutes of Health Stroke Scale (NIHSS) is a well-validated, reliable scoring system for use specifically with stroke patients.
The National Institutes of Health Stroke Scale (NIHSS) can be used as a standard measurement instrument by physicians to evaluate the severity of a patient and outcome.